Armistice Capital »

Norwegian Cruise Line Hldgs shares owned by Armistice Capital

Quarter-by-quarter ownership of Norwegian Cruise Line Hldgs (NCLH) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Norwegian Cruise Line Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Norwegian Cruise Line Hldgs held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Norwegian Cruise Line Hldgs by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $224k 14k 16.48

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Norwegian Cruise Line Hldgs

Vanguard Group
Two Sigma Investments
T. Rowe Price Associates
Citadel Advisors
Norges Bank Investment Management
Charles Schwab Investment Management
Barclays
Parallax Volatility Advisers
Dimensional Fund Advisors
Two Sigma Advisers
LMR Partners
Walleye Trading Advisors
Bank of New York Mellon
Patient Capital Management
Bnp Paribas Arbitrage, Snc

View all funds holding Norwegian Cruise Line Hldgs